Literature DB >> 30784815

Par3 regulates polarized convergence between APP and BACE1 in hippocampal neurons.

Miao Sun1, Chengyu Huang2, Hui Wang3, Huaye Zhang4.   

Abstract

The convergence between amyloid precursor protein (APP) and its β-secretase β-site APP cleaving enzyme 1 (BACE1) is a prerequisite for the generation of β-amyloid peptide, a key pathogenic agent for Alzheimer's disease. Yet the underlying molecular mechanisms regulating their convergence remain unclear. Here, we show that the polarity protein partitioning-defective 3 (Par3) regulates the polarized convergence between APP and BACE1 in hippocampal neurons. Par3 forms a complex with BACE1 through its first PDZ domain, which is important for regulating BACE1 endosome-to-TGN trafficking. In the absence of Par3, there is an increase in the convergence between internalized APP and BACE1. In hippocampal neurons, loss of Par3 leads to increased APP and BACE1 convergence in axons but not in dendrites. This polarized convergence mainly occurs in retrograde or stalled axonal late endocytic organelles and is likely due to compartment-specific regulation of APP trafficking by Par3. Together, our data show a novel function for Par3 in regulating polarized convergence between APP and BACE1 in hippocampal neurons.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APP; Alzheimer's disease; BACE1; Par3; Trafficking

Mesh:

Substances:

Year:  2019        PMID: 30784815      PMCID: PMC6528466          DOI: 10.1016/j.neurobiolaging.2019.01.023

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  41 in total

1.  Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice.

Authors:  Orly Lazarov; Michael Lee; Daniel A Peterson; Sangram S Sisodia
Journal:  J Neurosci       Date:  2002-11-15       Impact factor: 6.167

2.  The cell-polarity protein Par6 links Par3 and atypical protein kinase C to Cdc42.

Authors:  G Joberty; C Petersen; L Gao; I G Macara
Journal:  Nat Cell Biol       Date:  2000-08       Impact factor: 28.824

3.  Par-3 controls tight junction assembly through the Rac exchange factor Tiam1.

Authors:  Xinyu Chen; Ian G Macara
Journal:  Nat Cell Biol       Date:  2005-02-20       Impact factor: 28.824

Review 4.  Alzheimer's disease: channeling APP to non-amyloidogenic processing.

Authors:  Bor Luen Tang
Journal:  Biochem Biophys Res Commun       Date:  2005-06-03       Impact factor: 3.575

5.  Multiple splice variants of Par3 and of a novel related gene, Par3L, produce proteins with different binding properties.

Authors:  Lin Gao; Ian G Macara; Gérard Joberty
Journal:  Gene       Date:  2002-07-10       Impact factor: 3.688

6.  Rab5-stimulated up-regulation of the endocytic pathway increases intracellular beta-cleaved amyloid precursor protein carboxyl-terminal fragment levels and Abeta production.

Authors:  Olivera M Grbovic; Paul M Mathews; Ying Jiang; Stephen D Schmidt; Ravi Dinakar; Nicole B Summers-Terio; Brian P Ceresa; Ralph A Nixon; Anne M Cataldo
Journal:  J Biol Chem       Date:  2003-05-20       Impact factor: 5.157

7.  Direct binding of cell polarity protein PAR-3 to cell-cell adhesion molecule nectin at neuroepithelial cells of developing mouse.

Authors:  Kyoji Takekuni; Wataru Ikeda; Tsutomu Fujito; Koji Morimoto; Masakazu Takeuchi; Morito Monden; Yoshimi Takai
Journal:  J Biol Chem       Date:  2003-01-05       Impact factor: 5.157

8.  Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes.

Authors:  Ayae Kinoshita; Hiroaki Fukumoto; Tejal Shah; Christa M Whelan; Michael C Irizarry; Bradley T Hyman
Journal:  J Cell Sci       Date:  2003-06-26       Impact factor: 5.285

9.  The junctional adhesion molecule (JAM) family members JAM-2 and JAM-3 associate with the cell polarity protein PAR-3: a possible role for JAMs in endothelial cell polarity.

Authors:  Klaus Ebnet; Michel Aurrand-Lions; Annegret Kuhn; Friedemann Kiefer; Stefan Butz; Kerstin Zander; Maria-Katharina Meyer zu Brickwedde; Atsushi Suzuki; Beat A Imhof; Dietmar Vestweber
Journal:  J Cell Sci       Date:  2003-10-01       Impact factor: 5.285

10.  Junctional adhesion molecule (JAM) binds to PAR-3: a possible mechanism for the recruitment of PAR-3 to tight junctions.

Authors:  M Itoh; H Sasaki; M Furuse; H Ozaki; T Kita; S Tsukita
Journal:  J Cell Biol       Date:  2001-08-06       Impact factor: 10.539

View more
  4 in total

Review 1.  Willin/FRMD6: A Multi-Functional Neuronal Protein Associated with Alzheimer's Disease.

Authors:  Doris Chen; Wanjia Yu; Laura Aitken; Frank Gunn-Moore
Journal:  Cells       Date:  2021-11-04       Impact factor: 6.600

2.  Meta-analysis of genome-wide association studies identifies ancestry-specific associations underlying circulating total tau levels.

Authors:  Chloé Sarnowski; Mohsen Ghanbari; Joshua C Bis; Mark Logue; Myriam Fornage; Aniket Mishra; Shahzad Ahmad; Alexa S Beiser; Eric Boerwinkle; Vincent Bouteloup; Vincent Chouraki; L Adrienne Cupples; Vincent Damotte; Charles S DeCarli; Anita L DeStefano; Luc Djoussé; Alison E Fohner; Carol E Franz; Tiffany F Kautz; Jean-Charles Lambert; Michael J Lyons; Thomas H Mosley; Kenneth J Mukamal; Matthew P Pase; Eliana C Portilla Fernandez; Robert A Rissman; Claudia L Satizabal; Ramachandran S Vasan; Amber Yaqub; Stephanie Debette; Carole Dufouil; Lenore J Launer; William S Kremen; William T Longstreth; M Arfan Ikram; Sudha Seshadri
Journal:  Commun Biol       Date:  2022-04-08

3.  A novel non‑selective atypical PKC agonist could protect neuronal cell line from Aβ‑oligomer induced toxicity by suppressing Aβ generation.

Authors:  Dongmei Zou; Qian Li; Wenyang Pan; Peng Chen; Miao Sun; Xiaofeng Bao
Journal:  Mol Med Rep       Date:  2022-03-04       Impact factor: 2.952

Review 4.  Phosphorylation Signaling in APP Processing in Alzheimer's Disease.

Authors:  Tao Zhang; Dongmei Chen; Tae Ho Lee
Journal:  Int J Mol Sci       Date:  2019-12-27       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.